AKTS (Aktis Oncology) Days Payable: 0.00 (As of Mar. 2026)


AKTS Aktis Oncology Inc AKTS
9 GF Score
Price $32.47
! 3 Warning Signs
View Full Analysis

What is Aktis Oncology Days Payable?

Aktis Oncology AKTS +7.84% 9 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates AKTS with a GF Score™ of 9/100. The stock has 3 warning signs investors should review. Among 705 Biotechnology companies, Aktis Oncology ranks worse than 141843.83% on this metric.

Aktis Oncology's average Accounts Payable for the three months ended in Mar. 2026 was $1.48 Mil. Aktis Oncology's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Aktis Oncology's Days Payable or its related term are showing as below:

AKTS's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.36
* Ranked among companies with meaningful Days Payable only.

Aktis Oncology's Days Payable stayed the same from Dec. 2024 (0.00) to Mar. 2026 (0.00). stayed the same

Aktis Oncology Days Payable Historical Data

* Premium members only.

The historical data trend for Aktis Oncology's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aktis Oncology Days Payable Chart

Aktis Oncology Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Days Payable
0.00 0.00 0.00 0.00

Aktis Oncology Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

AKTS vs ZBIO, MLTX, AVBP: Days Payable Comparison

For the Biotechnology subindustry, Aktis Oncology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aktis Oncology Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aktis Oncology's Days Payable distribution charts can be found below:

* The bar in red indicates where Aktis Oncology's Days Payable falls into.


AKTS
9GF Score
Aktis Oncology Inc AKTS
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aktis Oncology Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Aktis Oncology's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (1.918 + 1.737) / 2 ) / 0*365
=1.8275 / 0*365
=N/A

Aktis Oncology's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (1.737 + 1.227) / 2 ) / 0*365 / 4
=1.482 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Aktis Oncology (AKTS) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aktis Oncology and its competitors. According to the industry distribution chart, Aktis Oncology ranks #999999 out of 705 companies in the Biotechnology industry.
Is Aktis Oncology's Days Payable too high?
Aktis Oncology's current Days Payable is 0.00. Based on the distribution chart, Aktis Oncology ranks #999999 out of 705 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Aktis Oncology has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Aktis Oncology's Days Payable compare to ZBIO and MLTX?
According to the Biotechnology industry distribution chart, Aktis Oncology ranks #999999 out of 705 companies for Days Payable. This places Aktis Oncology in the lower half of its industry. The industry median Days Payable is 113.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aktis Oncology and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aktis Oncology's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aktis Oncology stock overvalued right now?
Aktis Oncology (AKTS) has a current Days Payable of 0.00. The current Days Payable is 0.00. Aktis Oncology's overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Aktis Oncology (AKTS), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aktis Oncology Business Description

Address 17 Drydock Avenue, Suite 17-401, Boston, MA, USA, 02210
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.
9GF Score

Get the complete analysis for AKTS

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$32.47
Price